The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Choosing Your MedsChoosing Your Meds
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  • Email Email
  • Glossary Glossary

Resistance and what next?

Sep 28, 2012

Please help, on which medical i should use or choose since my resistance test came back positive on Aspen Efavirenz and Lamzid? which other medication i should use, i wanted to use Atripla, do you think is possible? even if i have resistance on efavirenz and lamzid?

Response from Dr. Young

Hello and thanks for posting.

It's good that you had a resistance test done before you started medications. Unfortunately, your apparently show transmitted multidrug resistance (to efavirenz, lamivudine and zidovudine/AZT). As such, you really should not use Atripla, ever, as a first regimen, since your resistance pattern predicts that 2 of the three medications in Atripla are compromised.

In cases like yours we typically start treatment of a boosted protease inhibitor, like darunavir (Prezista) or lopinavir (Kaletra). I'd recommend discussing these options with your doctor.

Be well, BY

PEP dosage and length
Truvada and Kaletra and drinking alcohol

  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint